Long-term rituximab cuts lymphoma recurrence risk Elderly lung CA patients benefit from aggressive chemo‘Remarkable’ four-month improvement in survival will change practice, researchers say Selenium a bust in lung cancer Supplement fails to prevent secondary tumour development Sponge-derived drug extends breast CA survival Eribulin among ‘handful’ of effective agents for metastatic disease Targeted lung cancer drug wows meeting Promising early trial results for crizotinib highlighted in plenary session Many NPs lack oncology expertise: study Supervising physicians act as educators for NPs new to oncology. Yondelis approved for relapsed ovarian cancer New drug delivery system: the nanosponge? Elderly lung cancer patients benefit from aggressive chemo 'Remarkable' four-month improvement in survival will change practice, researchers say Sponge-derived drug extends breast cancer survival First Previous 64 65 66 67 68 Next Last
